An initial nine price concessions for the month were announced on November 19.
Drug
Strength
Form
Price
Amiloride
5mg
tablets (28)
£19.50
Bumetanide
1mg
tablets (28)
£1.95
Co-careldopa
25mg/100mg
tablets (100)
£11.99
Dexamfetamine
5mg/5ml
sugar-free oral solution (500)
£381.63
Indapamide
2.5mg
tablets (28)
£2.20
Irbesartan
75mg
tablets (28)
£3.44
Irbesartan
150mg
tablets (28)
£6.33
Irbesartan
300mg
tablets (28)
£6.93
Levetiracetam
1g
tablets (60)
£12.50
Meloxicam
15mg
tablets (30)
£5.55
Memantine
10mg
tablets (28)
£3.30
Nefopam
30mg
tablets (90)
£7.99
Nifedipine
5mg
capsules (90)
£51.95
Nifedipine
10mg
capsules (90)
£65.63
Nitrofurantoin
100mg
tablets (28)
£10.68
Nizatidine
150mg
capsules (30)
£7.99
Oxytetracycline
250mg
tablets (28)
£4.99
Propranolol
10mg
tablets (28)
£2.00
Propranolol
40mg
tablets (28)
£2.00
Quinine sulfate
300mg
tablets (28)
£5.90
Ranitidine
150mg
tablets (60)
£4.07
Ranitidine
300mg
tablets (30)
£3.85
Certain batches of ranitidine-containing medicines have been subject to recall and quarantine, as the Medicines and Healthcare products Regulatory Agency (MHRA) investigates their potential contamination with N-nitrosodimethylamine (NDMA), which is a known risk factor for some cancers.
Last week (November 19), the MHRA announced the latest ranitidine-containing products to be recalled: Creo Pharma Limited's ranitidine oral solution 30mg/ml and Tillomed Laboratories Limited's ranitidine 150mg tablets.
